Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$35.32 USD
-0.69 (-1.92%)
Updated May 21, 2024 04:00 PM ET
After-Market: $35.30 -0.02 (-0.06%) 7:10 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Earnings News For KYMR
-
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
-
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: Should You Buy?
-
Will Kymera Therapeutics, Inc. (KYMR) Report Negative Q3 Earnings? What You Should Know
-
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Lags Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Misses Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Lags Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Lags Revenue Estimates
-
Analysts Estimate Kymera Therapeutics, Inc. (KYMR) to Report a Decline in Earnings: What to Look Out for
-
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Lags Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Tops Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) May Report Negative Earnings: Know the Trend Ahead of Q3 Release